Matters to be Discussed Clause Samples

POPULAR SAMPLE Copied 2 times
Matters to be Discussed. Any matter not stipulated in this agreement will be determined from time to time after consultation between Party A and Party B.
Matters to be Discussed. Discussions with employees and, where they choose, their representatives will include, where relevant, discussion of: a) measures that could be taken to remove or reduce the incidence of an employee becoming excess; b) redeployment prospects for the employee concerned; c) the appropriateness of using voluntary retrenchment; and d) the method of identifying an employee as excess, having regard to the efficient and economical working of the agency, and the relative efficiency of employees.
Matters to be Discussed. The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement #99000– K.
Matters to be Discussed. The meeting will include the review, discussion, and Contact Person For More Information: ▇▇▇▇
Matters to be Discussed. Agenda items will include a dialogue on issues that are
Matters to be Discussed. Agenda items will include a presentation and discussion on the ORRHES Web site, and updates and recommendations from the Public Health Assessment, Communications and Outreach, Agenda, Guidelines and Procedures, and the Health Education Needs Assessment Workgroups, and agency updates.
Matters to be Discussed. The meeting will include the review, discussion, and evaluation of applications received in response to: Validation of Stroke Care Quality Indicators for the ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ National Stroke Care Registry, Panel 2, Potential Extramural Project (PEP) R04.
Matters to be Discussed. Agenda items include issues pertaining to the epidemiology and control of Tuberculosis in low incidences counties and TB research priorities. Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). Name: National Vaccine Advisory Committee (NVAC). Times and Dates: 9 a.m.–2:15 p.m., May 22, 2000; 8:30 a.m.–12:45 p.m., May 23, 2000. Place: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ Building, Room 505A, ▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇, ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇. Status: Open to the public, limited only by the space available.
Matters to be Discussed. If any matter is not provided for in this Agreement or if any question arises between the parties concerning the interpretation of this Agreement, the Borrower, the Guarantor and the Lenders shall consult with each other through the Agent.
Matters to be Discussed. Agenda items will include updates from CDC Director, ▇▇▇▇▇ ▇▇▇▇▇▇▇, M.D., Ph.D., followed by committee discussion on strategic thinking about the Contact Person For More Information: ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇, Acting Executive Secretary, Advisory Committee to the Director, CDC, ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇, NE, M/S Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).